The stromal FoxP3+ Tregs may hinder inflammatory anti‐microbial activity allowing progression of the tumor, while intraepithelial FoxP3+ Tregs may inhibit, possibly directly contacting with tumor cells, antitumoral immune activity.46 The gene discussed is FOXP3; the disease is neoplasm.